Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.55 - $1.26 $2,838 - $6,501
-5,160 Reduced 9.55%
48,894 $34,000
Q1 2023

May 15, 2023

SELL
$0.89 - $2.52 $9,741 - $27,583
-10,946 Reduced 16.84%
54,054 $48,000
Q4 2022

Feb 14, 2023

SELL
$1.02 - $7.48 $35,700 - $261,800
-35,000 Reduced 35.0%
65,000 $77,000
Q3 2022

Nov 14, 2022

SELL
$6.04 - $9.66 $246,123 - $393,635
-40,749 Reduced 28.95%
100,000 $753,000
Q2 2022

Aug 15, 2022

SELL
$4.99 - $8.96 $71,112 - $127,688
-14,251 Reduced 9.19%
140,749 $887,000
Q1 2022

May 16, 2022

SELL
$3.84 - $9.74 $209,003 - $530,128
-54,428 Reduced 25.99%
155,000 $1.29 Million
Q4 2021

Feb 14, 2022

SELL
$5.12 - $8.19 $18,288 - $29,254
-3,572 Reduced 1.68%
209,428 $1.09 Million
Q3 2021

Nov 15, 2021

BUY
$6.68 - $9.1 $40,080 - $54,600
6,000 Added 2.9%
213,000 $1.42 Million
Q2 2021

Aug 16, 2021

BUY
$7.82 - $9.23 $54,740 - $64,610
7,000 Added 3.5%
207,000 $1.76 Million
Q1 2021

May 14, 2021

BUY
$8.44 - $12.66 $20,703 - $31,054
2,453 Added 1.24%
200,000 $1.77 Million
Q4 2020

Feb 16, 2021

BUY
$7.98 - $12.29 $44,265 - $68,172
5,547 Added 2.89%
197,547 $2.43 Million
Q3 2020

Nov 16, 2020

BUY
$7.96 - $12.42 $55,720 - $86,940
7,000 Added 3.78%
192,000 $1.56 Million
Q2 2020

Aug 14, 2020

BUY
$5.4 - $13.37 $156,600 - $387,730
29,000 Added 18.59%
185,000 $1.78 Million
Q1 2020

May 15, 2020

BUY
$4.91 - $14.7 $29,460 - $88,200
6,000 Added 4.0%
156,000 $1.06 Million
Q4 2019

Feb 14, 2020

BUY
$9.77 - $15.66 $97,700 - $156,600
10,000 Added 7.14%
150,000 $2.24 Million
Q3 2019

Nov 14, 2019

BUY
$9.59 - $12.0 $95,900 - $120,000
10,000 Added 7.69%
140,000 $1.44 Million
Q2 2019

Aug 14, 2019

BUY
$9.54 - $14.96 $238,499 - $374,000
25,000 Added 23.81%
130,000 $1.38 Million
Q4 2018

Feb 14, 2019

BUY
$8.63 - $12.4 $604,100 - $868,000
70,000 Added 200.0%
105,000 $1.07 Million
Q3 2018

Nov 14, 2018

BUY
$9.6 - $12.9 $336,000 - $451,500
35,000 New
35,000 $420,000

Others Institutions Holding EIGR

About Eiger BioPharmaceuticals, Inc.


  • Ticker EIGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,966,800
  • Market Cap $418M
  • Description
  • Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...
More about EIGR
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.